Session Information
Date: Thursday, June 23, 2016
Session Title: Clinical trials and therapy in movement disorders
Session Time: 12:00pm-1:30pm
Location: Exhibit Hall located in Hall B, Level 2
Objective: A multidisciplinary specialized treatment including physiotherapy, speech and language therapy, occupational therapy (OT) associated to the ideal pharmacological treatment and surgical is recommended to Parkinson’s disease(PD).
Background: Identify the most effective Rehabilitation treatment for the PD, determine the classification of the analyzed studies and the level of the recommendation of non pharmacological therapies.
Methods: It was made a search in the electronic database of Medline, Cochrane Library, Lilacs. The key words Rehabilitation in Parkinson’s disease, Physiotherapy, Exercises, Speech and language therapy and Occupational Therapy were used in Portuguese and English, and it has comprehended the period from 2005 to the beginning of March 2015. The research was performed separately by independent reviewers. Only the articles which reported a project of randomized controlled study (RTC) in human beings with PD were included. Studies were classified to the evidence level (class I, II, III or IV) according to the adopted classification of the American Neurology Academy.
Results: It was found 83 RTC in this review involving 1729 participants. The RTC were separated by modality and criteria of evidence level (class I or II).The evidences show nonpharmacological treatment adopted by multidisciplinary team focusing on the control of the parkisoninan symptoms and on compensatory strategies. RTC of physiotherapy with sensorial cues are effective for people with PD (class I and II). The intervention in long term must be recommended (Level A) and practice physical exercises to patients with PD (Level A). The speech therapy is important to the rehabilitation program of patients with PD. The LSVT methodology is the recognized treatment in the vocal therapy. The speech and language therapy must be preconized in patients with PD because the works show an improvement of this intervention in the voice and in the dysphagia (Voice Level B and Dysphagia Level C). A recent study Class I suggests that the OT helps the patients with PD in the ADL when compared to control, however the effects of OT were not sustained in long term. This intervention is recommended to patients with PD (level B).
Conclusions: The nonpharmacological therapies must be recommended to patients with PD. Future studies are necessary to establish the dosage, efficiency and long term effectiveness intervention.
To cite this abstract in AMA style:
T.T.C. Capato, C.H. Fen, E.R. Barbosa. Classification and recommendation of nonpharmacological therapies for Parkinson’s disease [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/classification-and-recommendation-of-nonpharmacological-therapies-for-parkinsons-disease/. Accessed November 21, 2024.« Back to 2016 International Congress
MDS Abstracts - https://www.mdsabstracts.org/abstract/classification-and-recommendation-of-nonpharmacological-therapies-for-parkinsons-disease/